---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-201313"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:59:52.691881+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics board changes: Chairman Mario resigns for health; Dawn Bir appointed as director

## Summary
- Chairman Ernest Mario resigns effective August 15, 2024 for health reasons; no disagreement with company.
- Dawn Carter Bir appointed to board effective August 15, 2024; receives 13,000 RSUs vesting over 3 years.
- Matthew Pauls named Lead Independent Director; Andrew Sinclair chairs Compensation Committee.
- Bir brings over 30 years biotech experience, led commercial launches at Reata and Pharmacyclics.

## SEC filing metadata
- accession: 0001193125-24-201313
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/d856535d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-201313
- JSON: https://secwatch.observer/filing/0001193125-24-201313.json
- Plain text: https://secwatch.observer/filing/0001193125-24-201313.txt

## Key facts
- Executive change
  Dawn C. Bir was appointed as Director at SOLENO THERAPEUTICS INC.
  - Action: appointed
  - Role: Director
  source text: On August 13, 2024, the Board appointed Dawn C. Bir to the Board effective upon Dr. Mario’s retirement on August 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm
- Executive change
  Ernest Mario resigned as Chairman of the Board at SOLENO THERAPEUTICS INC.
  - Action: resigned
  - Role: Chairman of the Board
  source text: On August 9, 2024, Dr. Ernest Mario, the Chairman of the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”), notified the Company that he intended to resign from the Board for health reasons effective as of August 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.